Price Alert

aTyr Pharma Inc. (ATYR)

NASDAQ: ATYR · Real-Time Price · USD

4.90

-0.09 (-1.80%)

At close: Aug 15, 2025, 3:59 PM

4.93

0.61%

After-hours: Aug 15, 2025, 07:48 PM EDT

aTyr Pharma Balance Sheet Statement

Financials in USD. Fiscal year is undefined.

Fiscal Year	Q2 2025	Q1 2025	Q4 2024	Q3 2024	Q2 2024	Q1 2024	Q4 2023	Q3 2023	Q2 2023	Q1 2023	Q4 2022	Q3 2022	Q2 2022	Q1 2022	Q4 2021	Q3 2021	Q2 2021	Q1 2021
Period Ending	Jun 30, 2025	Mar 31, 2025	Dec 31, 2024	Sep 30, 2024	Jun 30, 2024	Mar 31, 2024	Dec 31, 2023	Sep 30, 2023	Jun 30, 2023	Mar 31, 2023	Dec 31, 2022	Sep 30, 2022	Jun 30, 2022	Mar 31, 2022	Dec 31, 2021	Sep 30, 2021	Jun 30, 2021	Mar 31, 2021
Cash & Equivalents	17.22M	10.36M	11.05M	11.46M	6.8M	6.81M	22.54M	9.79M	12.31M	20.69M	9.98M	18.36M	8.48M	8.32M	2.34M	59.74M	2.19M	12.59M
Short-Term Investments	63.13M	65.99M	61.07M	54.53M	71.68M	77.69M	75.62M	92.34M	96.27M	93.69M	56.16M	59.02M	80.07M	90.34M	105.58M	56.61M	41.87M	38.05M
Long-Term Investments	2.88M	n/a	n/a	2.93M	2.9M	3.21M	3.48M	3.45M	3.42M	3.19M	3.17M	2.24M	733K	n/a	n/a	n/a	n/a	n/a
Other Long-Term Assets	66K	2.5M	3.02M	130K	130K	130K	131K	73K	72K	144K	193K	169K	175K	176K	158K	158K	152K	234K
Receivables	498K	988K	1.74M	1.83M	1.63M	2.48M	2.44M	2.09M	1.29M	1.63M	11.78M	873K	426K	426K	435K	129K	90K	89K
Inventory	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Other Current Assets	63.13M	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Total Current Assets	87.49M	83.27M	81.95M	76.32M	90.3M	96.92M	102.99M	107.3M	114.43M	119.45M	80.87M	84.63M	93.36M	103.12M	113.57M	121.57M	46.41M	52.13M
Property-Plant & Equipment	11.1M	11.48M	11.86M	12.24M	12.62M	12.99M	14.05M	14.25M	14.82M	14.06M	11.56M	9.01M	1.75M	1.48M	1.81M	2.19M	2.44M	2.76M
Goodwill & Intangibles	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Total Long-Term Assets	14.04M	13.97M	14.88M	15.3M	15.64M	16.34M	19.07M	17.77M	18.32M	17.39M	14.91M	11.42M	2.66M	1.66M	1.97M	2.34M	2.59M	2.99M
Total Assets	101.53M	97.25M	96.83M	91.62M	105.94M	113.25M	122.07M	125.07M	132.75M	136.84M	95.79M	96.06M	96.02M	104.78M	115.54M	123.92M	48.99M	55.13M
Account Payables	3.88M	1.53M	4.32M	3.95M	1.25M	4.89M	3.53M	2.04M	516K	3.96M	3.11M	3.13M	1.67M	1.56M	1.03M	900K	2.22M	1.16M
Deferred Revenue	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Short-Term Debt	1.33M	1.29M	1.25M	1.21M	1.17M	1.14M	1.33M	1.23M	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Other Current Liabilities	10.32M	-1.29M	5.05M	-1.21M	-1.17M	-1.14M	-1.33M	-1.23M	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Total Current Liabilities	15.53M	10.68M	14.97M	14.12M	11.84M	15.98M	16.42M	12.88M	12.37M	13.65M	13.86M	11.21M	9.26M	6.27M	6.01M	5.82M	7.28M	4.45M
Long-Term Debt	11.35M	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Other Long-Term Liabilities	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Total Long-Term Liabilities	11.35M	11.7M	12.03M	12.36M	12.68M	12.99M	15.18M	13.98M	14.33M	13.49M	10.64M	7.84M	298K	133K	398K	657K	906K	1.15M
Total Liabilities	26.88M	22.38M	27M	26.48M	24.52M	28.97M	31.6M	26.87M	26.7M	27.14M	24.5M	19.05M	9.56M	6.4M	6.41M	6.48M	8.19M	5.6M
Total Debt	12.68M	12.99M	13.28M	13.57M	13.85M	14.13M	15.1M	15.22M	15.39M	14.29M	11.53M	8.65M	1.27M	1.15M	1.38M	1.61M	1.82M	2.04M
Common Stock	93K	89K	84K	76K	76K	68K	63K	59K	57K	53K	29K	29K	28K	28K	28K	28K	16K	16K
Retained Earnings	-566.46M	-546.93M	-532.05M	-517.08M	-499.82M	-483.51M	-468.02M	-453.26M	-441.92M	-429.58M	-417.63M	-410.11M	-396.87M	-384.45M	-372.3M	-363.74M	-356.07M	-345.68M
Comprehensive Income	-75K	-66K	-40K	36K	-168K	-158K	-74K	-294K	-333K	-248K	-433K	-669K	-810K	-759K	-263K	-69K	-61K	-57K
Shareholders Equity	74.84M	75.05M	70.02M	65.33M	81.61M	84.47M	90.66M	98.39M	106.24M	109.88M	71.46M	77.18M	86.64M	98.55M	109.3M	117.61M	40.98M	49.7M
Total Investments	66M	65.99M	61.07M	54.53M	74.57M	80.9M	79.11M	95.8M	99.69M	96.89M	59.33M	61.25M	80.8M	90.34M	105.58M	56.61M	41.87M	38.05M